Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by EDAP TMS S.A.

Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Announces Scientific Presentation Highlighting Feasibility of Focal One® to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America Meeting
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Reports Third Quarter 2024 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP to Participate in the 2024 Jefferies London Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Announces First Patients Treated in Phase I/II Study Evaluating Focal One Robotic HIFU for the Treatment of Benign Prostatic Hyperplasia (BPH)
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Reports Second Quarter 2024 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP’s Focal One Robotic HIFU Platform to be Featured at 41st World Congress of Endourology and Uro-Technology Meeting (WCET 2024)
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Appoints Fran Schulz to Board of Directors
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP to Present at the Jefferies Global Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Reports First Quarter 2024 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.